So the key catalyst will be the P3 OA top line readout, potentially around October 2024, and only if the FDA allow us to up the dose to 2mg/kg, making the meeting with the FDA another key catalyst. It is possible regional deals could be struck prior to this readout given that potential partners may want to lock in a deal beforehand or risk having to pay more if the top line readout is a smashing success. PAR should have enough data to secure an upfront payment prior to the top line readout.
- Forums
- ASX - By Stock
- Ann: PAR Successful Placement and Fully Underwritten ANREO
So the key catalyst will be the P3 OA top line readout,...
-
- There are more pages in this discussion • 184 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAR (ASX) to my watchlist
|
|||||
Last
24.5¢ |
Change
0.015(6.52%) |
Mkt cap ! $85.7M |
Open | High | Low | Value | Volume |
23.0¢ | 24.5¢ | 23.0¢ | $116.0K | 491.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 50000 | 23.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
24.5¢ | 33682 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 50000 | 0.235 |
2 | 44021 | 0.230 |
1 | 100000 | 0.225 |
5 | 234973 | 0.220 |
4 | 96293 | 0.215 |
Price($) | Vol. | No. |
---|---|---|
0.245 | 33682 | 3 |
0.250 | 59284 | 5 |
0.255 | 21666 | 2 |
0.260 | 41294 | 6 |
0.265 | 37500 | 2 |
Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |
The Watchlist
FHE
FRONTIER ENERGY LIMITED
Adam Kiley, CEO
Adam Kiley
CEO
SPONSORED BY The Market Online